Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215644
Status:
COMPLETED
Last Update Posted:
2018-11-02
First Post:
2005-09-15
Brief Title:
Matuzumab Treatment With Epirubicin Cisplatin and Capecitabine ECX in Esophago-Gastric Cancer
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2008-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-15
First Submit QC Date:
September 15 2005
Study First Post Date:
2005-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-11-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-27
Last Update Post Date:
2018-11-02
Last Update Post Date Type:
ACTUAL